Fiki Muhammad Ridho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fiki Muhammad Ridho has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Ridwan Alfatah
Faculty of Medicine, Universitas Islam Negeri Walisongo, Semarang, Indonesia, Indonesia
6 shared publications - Anis Irmawati
Department of Basic Dental Science and Public Health, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
5 shared publications - Eko Puji Laksono
Tarakan General Hospital, Jakarta, Indonesia, Indonesia
4 shared publications - Raed Labib
Department of Oral Surgery, Faculty of Dental Medicine, 21 September University of Medical and Applied Sciences. Sana'a, Yemen.Department of Oral Surgery Faculty of Dental Medicine 21 September University of Medical and Applied Sciences Sana'a Yemen
4 shared publications Alfi Syahri
Department of Surgical Medical Nursing Faculty of Nursing Universitas Airlangga Surabaya
3 shared publicationsAndika Julyanto Syachputra
Master Program in Biology, Faculty of Biology, Universitas Gadjah Mada, Yogyakarta-Indonesia
3 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Universitas Negeri Yogyakarta in Journal of Medical Science and Sports Health
- Vol. 2 (2) , 54-79
The The Effects of Omega-3 Fatty Acids on Cardiometabolic Indices and Inflammatory Markers in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Placebo-controlled Trials
Introduction: Type 2 diabetes mellitus (T2DM) remains a global health problem associated with cardiovascular risk. This study aims to study the effects of marine-derived omega-3 fatty acids (n3-FA), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on cardiometabolic indices and inflammatory markers in patients with T2DM through systematic review and metanalysis of RCTs. Methods: Systematic review was conducted on RCTs published in PubMed/MEDLINE, Scopus, Web of Science, ScienceDirect, and Cochrane Library. Risk of bias was evaluated using Cochrane RoB2. Pooled analyses were performed using random-effects model and expressed as mean differences (MD) or odds ratio (OR) with 95% confidence intervals (CI). Evidence certainty was assessed using GRADE approach. Results: Thirty-seven RCTs (n=2,423 patients) were included. n3-FA significantly improved HbA1c (MD= -0.29 [95% CI: -0.50, -0.08]; I2=92%), insulin resistance (MD= -0.53 [-0.88, -0.18]; I2=70%), BMI (MD= -0.42 [-0.76, -0.08]; I2=0%), total cholesterol (MD= -6.39 [-12.57, -0.21]; I2=74%), HDL (MD= 1.37 [0.02, 2.73]; I2=59%), triglycerides (MD= -32.55 [-46.35, -18.74]; I2=84%), TNF-α (MD= -2.97 [-5.10, -0.84]; I2=86%), and CRP (MD= -0.83 [-1.26, -0.40]; I2=70%) compared with placebo (p <0.05). No significant changes were observed in blood glucose, blood pressure, LDL, and IL-6. n3-FA was well tolerated with safety profile similar to placebo (OR= 0.84; 95% CI: 0.41–1.72). GRADE evaluation showed moderate-to-very low level of evidence. Conclusion: n3-FA associated with improvements on cardiometabolic indices (HbA1c, insulin resistance, BMI, total cholesterol, HDL, and triglycerides) and inflammatory markers (TNF-α and CRP) in T2DM patients. Interpretation should be cautious due to high heterogeneity and varying evidence certainty. Large-scale studies with rigorous methodology are needed to support clinical recommendations.
- 1 October 2026
- Published by Universitas Negeri Yogyakarta in Journal of Medical Science and Sports Health
- Vol. 2 (2) , 54-79
Open AccessThe The Effects of Omega-3 Fatty Acids on Cardiometabolic Indices and Inflammatory Markers in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Placebo-controlled Trials
Introduction: Type 2 diabetes mellitus (T2DM) remains a global health problem associated with cardiovascular risk. This study aims to study the effects of marine-derived omega-3 fatty acids (n3-FA), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on cardiometabolic indices and inflammatory markers in patients with T2DM through systematic review and metanalysis of RCTs. Methods: Systematic review was conducted on RCTs published in PubMed/MEDLINE, Scopus, Web of Science, ScienceDirect, and Cochrane Library. Risk of bias was evaluated using Cochrane RoB2. Pooled analyses were performed using random-effects model and expressed as mean differences (MD) or odds ratio (OR) with 95% confidence intervals (CI). Evidence certainty was assessed using GRADE approach. Results: Thirty-seven RCTs (n=2,423 patients) were included. n3-FA significantly improved HbA1c (MD= -0.29 [95% CI: -0.50, -0.08]; I2=92%), insulin resistance (MD= -0.53 [-0.88, -0.18]; I2=70%), BMI (MD= -0.42 [-0.76, -0.08]; I2=0%), total cholesterol (MD= -6.39 [-12.57, -0.21]; I2=74%), HDL (MD= 1.37 [0.02, 2.73]; I2=59%), triglycerides (MD= -32.55 [-46.35, -18.74]; I2=84%), TNF-α (MD= -2.97 [-5.10, -0.84]; I2=86%), and CRP (MD= -0.83 [-1.26, -0.40]; I2=70%) compared with placebo (p <0.05). No significant changes were observed in blood glucose, blood pressure, LDL, and IL-6. n3-FA was well tolerated with safety profile similar to placebo (OR= 0.84; 95% CI: 0.41–1.72). GRADE evaluation showed moderate-to-very low level of evidence. Conclusion: n3-FA associated with improvements on cardiometabolic indices (HbA1c, insulin resistance, BMI, total cholesterol, HDL, and triglycerides) and inflammatory markers (TNF-α and CRP) in T2DM patients. Interpretation should be cautious due to high heterogeneity and varying evidence certainty. Large-scale studies with rigorous methodology are needed to support clinical recommendations.
- Open Access
- 10 July 2026
- Published by Universidad Cientifica del Sur in Revista Científica Odontológica
- Vol. 14 (3) , e307
A RARE CASE OF ODONTOGENIC MYXOFIBROMA OF THE MAXILLA IN A YOUNG PATIENT: A CHALLENGING DIAGNOSTIC AND DIFFERENTIAL DIAGNOSIS
El mixofibroma odontogénico es un tumor mesenquimal benigno, pero localmente agresivo, de crecimiento lento y expansivo, que se observa con mayor frecuencia en mujeres y afecta principalmente la mandíbula posterior, con rara afectación del maxilar. Este tumor representa aproximadamente el 3-6% de los tumores odontogénicos. Este artículo describe un caso poco frecuente de un varón de 17 años que presentó una historia de dos años de aumento de volumen en el lado derecho de la cara, que afectaba las áreas bucal y palatina del maxilar posterior. Clínicamente, la lesión presentó una consistencia dura con coloración normal de los tejidos circundantes, no estaba ulcerada ni era dolorosa a la palpación, y tampoco mostró signos de sangrado. El tumor fue completamente removido y el hueso remanente se estabilizó mediante el uso de una miniplaca. En la evaluación de seguimiento a los 16 meses, no se observó evidencia clínica ni radiográfica de recurrencia tumoral. Este caso pone de manifiesto los desafíos diagnósticos asociados con el mixofibroma odontogénico del maxilar debido a sus características clínicas y radiográficas inespecíficas, así como subraya la importancia de la confirmación histopatológica para un diagnóstico preciso y un manejo adecuado.
- 10 July 2026
- Published by Universidad Cientifica del Sur in Revista Científica Odontológica
- Vol. 14 (3) , e307
Open AccessA RARE CASE OF ODONTOGENIC MYXOFIBROMA OF THE MAXILLA IN A YOUNG PATIENT: A CHALLENGING DIAGNOSTIC AND DIFFERENTIAL DIAGNOSIS
El mixofibroma odontogénico es un tumor mesenquimal benigno, pero localmente agresivo, de crecimiento lento y expansivo, que se observa con mayor frecuencia en mujeres y afecta principalmente la mandíbula posterior, con rara afectación del maxilar. Este tumor representa aproximadamente el 3-6% de los tumores odontogénicos. Este artículo describe un caso poco frecuente de un varón de 17 años que presentó una historia de dos años de aumento de volumen en el lado derecho de la cara, que afectaba las áreas bucal y palatina del maxilar posterior. Clínicamente, la lesión presentó una consistencia dura con coloración normal de los tejidos circundantes, no estaba ulcerada ni era dolorosa a la palpación, y tampoco mostró signos de sangrado. El tumor fue completamente removido y el hueso remanente se estabilizó mediante el uso de una miniplaca. En la evaluación de seguimiento a los 16 meses, no se observó evidencia clínica ni radiográfica de recurrencia tumoral. Este caso pone de manifiesto los desafíos diagnósticos asociados con el mixofibroma odontogénico del maxilar debido a sus características clínicas y radiográficas inespecíficas, así como subraya la importancia de la confirmación histopatológica para un diagnóstico preciso y un manejo adecuado.
- Open Access
- 10 July 2026
- Published by Universidad Cientifica del Sur in Revista Científica Odontológica
- Vol. 14 (3) , e303
EFFICACY OF OMEGA-3 FATTY ACIDS SUPPLEMENTATION AS AN ADJUNCT TO NONSURGICAL PERIODONTAL THERAPY IN PERIODONTITIS: A SYSTEMATIC REVIEW AND METAANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Introduction: This study aimed to evaluate the efficacy of omega-3 fatty acids (n3-FA) supplementation as adjunct to scaling and root planing (SRP) in patients with periodontitis. Methods: A systematic review of randomized controlled trials (RCTs) evaluating n3-FA supplementation as a single adjunct therapy for SRP was conducted through a comprehensive search in Scopus, PubMed, Web of Science, Cochrane Library, and EBSCO. The Cochrane RoB2 tool was used as a tool for evaluating risk of bias. The outcomes of probing pocket depth (PPD) and clinical attachment level (CAL) were analyzed using a random-effects model metaanalysis and reported as mean differences (MD) and 95% confidence intervals (CI). The certainty of evidence was evaluated using the GRADE approach. RevMan 5.4 software was used for all statistical analysis. Results: Nine RCTs were included in the meta-analysis. Compared with SRP alone, adjunctive n3-FA supplementation showed a greater reduction in PPD (MD = -0.66; 95% CI: -1.03, -0.30; p = 0.0003; I2 = 91%) and gain in CAL (MD = -0.69; 95% CI: -1.06, -0.32; p =0.0002; I2 = 88%). Sensitivity and subgroup analyses yielded consistent effect directions, although the overall certainty of evidence was rated as low. Conclusion: Adjunctive n3-FA supplementation as a host modulation therapy may provide additional benefits when combined with SRP in patients with periodontitis. However, given the substantial heterogeneity and low level of evidence, these findings should be interpreted cautiously. Further high-quality, more rigorously designed RCTs are required to confirm their long-term efficacy and safety.
- 10 July 2026
- Published by Universidad Cientifica del Sur in Revista Científica Odontológica
- Vol. 14 (3) , e303
Open AccessEFFICACY OF OMEGA-3 FATTY ACIDS SUPPLEMENTATION AS AN ADJUNCT TO NONSURGICAL PERIODONTAL THERAPY IN PERIODONTITIS: A SYSTEMATIC REVIEW AND METAANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Introduction: This study aimed to evaluate the efficacy of omega-3 fatty acids (n3-FA) supplementation as adjunct to scaling and root planing (SRP) in patients with periodontitis. Methods: A systematic review of randomized controlled trials (RCTs) evaluating n3-FA supplementation as a single adjunct therapy for SRP was conducted through a comprehensive search in Scopus, PubMed, Web of Science, Cochrane Library, and EBSCO. The Cochrane RoB2 tool was used as a tool for evaluating risk of bias. The outcomes of probing pocket depth (PPD) and clinical attachment level (CAL) were analyzed using a random-effects model metaanalysis and reported as mean differences (MD) and 95% confidence intervals (CI). The certainty of evidence was evaluated using the GRADE approach. RevMan 5.4 software was used for all statistical analysis. Results: Nine RCTs were included in the meta-analysis. Compared with SRP alone, adjunctive n3-FA supplementation showed a greater reduction in PPD (MD = -0.66; 95% CI: -1.03, -0.30; p = 0.0003; I2 = 91%) and gain in CAL (MD = -0.69; 95% CI: -1.06, -0.32; p =0.0002; I2 = 88%). Sensitivity and subgroup analyses yielded consistent effect directions, although the overall certainty of evidence was rated as low. Conclusion: Adjunctive n3-FA supplementation as a host modulation therapy may provide additional benefits when combined with SRP in patients with periodontitis. However, given the substantial heterogeneity and low level of evidence, these findings should be interpreted cautiously. Further high-quality, more rigorously designed RCTs are required to confirm their long-term efficacy and safety.
- 24 June 2026
- Published by Yeungnam University College of Medicine in Journal of Yeungnam Medical Science
- Vol. 43, 42
Therapeutic efficacy of mesenchymal stem cells in periodontal regeneration: a systematic review and meta-analysis of clinical trials
Background: Periodontitis is a major global health problem that leads to destruction and loss of periodontal tissues. As conventional therapy has a limited capacity to restore the complex architecture of the periodontium, regenerative approaches have been explored. This meta-analysis evaluates the therapeutic efficacy of mesenchymal stem cells (MSCs) for periodontal regeneration in patients with periodontal defects.Methods: PubMed, Scopus, Web of Science, Dentistry & Oral Sciences Source, and the Cochrane Library were searched for clinical trials. The risk of bias was assessed using Cochrane RoB2. Random- or fixed-effects meta-analyses were used in the pooled analysis and reported as mean differences (MDs) and 95% confidence intervals (CIs). Certainty of evidence was rated using Grading of Recommendations, Assessment, Development, and Evaluation (GRADE).Results: Ten clinical trials were included in the analysis. MSCs significantly improved probing pocket depth (MD, –0.51; 95% CI, –0.84 to –0.19; p<0.01; I2=62%), clinical attachment level (MD, –0.75; 95% CI, –0.95 to –0.54; p<0.01; I2=40%), cementoenamel junction to the base of defect (MD, –0.49; 95% CI, –0.95 to –0.02; p=0.04; I2=63%), and intrabony defect (MD, –1.09; 95% CI, –1.60 to –0.57; p<0.01; I2=71%). However, no significant improvement in gingival recession was observed (MD, –0.18; 95% CI, –0.38 to 0.01; p=0.07; I2=0%). The GRADE assessment indicated a high-to-moderate certainty.Conclusion: MSCs represent a promising strategy for periodontal regeneration. Nevertheless, the limited number of studies and the observed heterogeneity warrant cautious interpretation. Larger methodologically rigorous trials are needed to clarify the true contribution of MSCs to periodontal regeneration.
- 24 June 2026
- Published by Yeungnam University College of Medicine in Journal of Yeungnam Medical Science
- Vol. 43, 42
Therapeutic efficacy of mesenchymal stem cells in periodontal regeneration: a systematic review and meta-analysis of clinical trials
Background: Periodontitis is a major global health problem that leads to destruction and loss of periodontal tissues. As conventional therapy has a limited capacity to restore the complex architecture of the periodontium, regenerative approaches have been explored. This meta-analysis evaluates the therapeutic efficacy of mesenchymal stem cells (MSCs) for periodontal regeneration in patients with periodontal defects.Methods: PubMed, Scopus, Web of Science, Dentistry & Oral Sciences Source, and the Cochrane Library were searched for clinical trials. The risk of bias was assessed using Cochrane RoB2. Random- or fixed-effects meta-analyses were used in the pooled analysis and reported as mean differences (MDs) and 95% confidence intervals (CIs). Certainty of evidence was rated using Grading of Recommendations, Assessment, Development, and Evaluation (GRADE).Results: Ten clinical trials were included in the analysis. MSCs significantly improved probing pocket depth (MD, –0.51; 95% CI, –0.84 to –0.19; p<0.01; I2=62%), clinical attachment level (MD, –0.75; 95% CI, –0.95 to –0.54; p<0.01; I2=40%), cementoenamel junction to the base of defect (MD, –0.49; 95% CI, –0.95 to –0.02; p=0.04; I2=63%), and intrabony defect (MD, –1.09; 95% CI, –1.60 to –0.57; p<0.01; I2=71%). However, no significant improvement in gingival recession was observed (MD, –0.18; 95% CI, –0.38 to 0.01; p=0.07; I2=0%). The GRADE assessment indicated a high-to-moderate certainty.Conclusion: MSCs represent a promising strategy for periodontal regeneration. Nevertheless, the limited number of studies and the observed heterogeneity warrant cautious interpretation. Larger methodologically rigorous trials are needed to clarify the true contribution of MSCs to periodontal regeneration.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Journal of Applied Oral Science
- Vol. 34
Potency of moderate-intensity exercise on caspase-8 and caspase-9 expression in a DMBA-induced oral epithelial dysplasia rat model
Background Oral squamous cell carcinoma (OSCC) accounts for approximately 90% of oral cancers, with tobacco exposure representing one of its major risk factors. The tobacco carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) induces oral epithelial dysplasia, a premalignant lesion. Caspase-8 and caspase-9 are initiator caspases that trigger apoptosis in dysplastic cells. Currently, disease management focuses on prevention. Moderate-intensity exercise has been reported to modulate apoptosis-related signaling and may contribute to cancer prevention. Objective To evaluate the potency of moderate-intensity exercise on caspase-8 and -9 expression in a DMBA-induced oral dysplasia rat model. Methodology A total of 24 Wistar rats were randomly divided into four groups: K1 (no exercise, no DMBA), K2 (exercise, no DMBA), K3 (no exercise, DMBA), K4 (exercise, DMBA). Exercise consisted of moderate-intensity swimming at 70% MWC, performed 3x/week for 6 weeks. DMBA (0.02 mg/kg body weight) was injected into the buccal mucosa of the canine region twice weekly for 2 weeks. At the 7th week, the rats were anesthetized with ketamine (10 mg/kg body weight), euthanized by cervical dislocation, and buccal tissue specimens were collected. Immunohistochemical staining was performed to obtain caspase-8 and -9 expression. Data were analyzed in SPSS version 29.0. Results All groups presented significant differences in caspase-8 (p = 0.004) and caspase-9 (p <0.001) expression. Caspase-8 and caspase-9 expression was significantly higher in K4 than in K3, with expression restored to levels comparable to the untreated control group (K1). Conclusion Moderate-intensity exercise restored caspase-8 and caspase-9 expression suppressed by DMBA exposure, suggesting preservation of apoptotic signaling in DMBA-induced Wistar rats.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Journal of Applied Oral Science
- Vol. 34
Open AccessPotency of moderate-intensity exercise on caspase-8 and caspase-9 expression in a DMBA-induced oral epithelial dysplasia rat model
Background Oral squamous cell carcinoma (OSCC) accounts for approximately 90% of oral cancers, with tobacco exposure representing one of its major risk factors. The tobacco carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) induces oral epithelial dysplasia, a premalignant lesion. Caspase-8 and caspase-9 are initiator caspases that trigger apoptosis in dysplastic cells. Currently, disease management focuses on prevention. Moderate-intensity exercise has been reported to modulate apoptosis-related signaling and may contribute to cancer prevention. Objective To evaluate the potency of moderate-intensity exercise on caspase-8 and -9 expression in a DMBA-induced oral dysplasia rat model. Methodology A total of 24 Wistar rats were randomly divided into four groups: K1 (no exercise, no DMBA), K2 (exercise, no DMBA), K3 (no exercise, DMBA), K4 (exercise, DMBA). Exercise consisted of moderate-intensity swimming at 70% MWC, performed 3x/week for 6 weeks. DMBA (0.02 mg/kg body weight) was injected into the buccal mucosa of the canine region twice weekly for 2 weeks. At the 7th week, the rats were anesthetized with ketamine (10 mg/kg body weight), euthanized by cervical dislocation, and buccal tissue specimens were collected. Immunohistochemical staining was performed to obtain caspase-8 and -9 expression. Data were analyzed in SPSS version 29.0. Results All groups presented significant differences in caspase-8 (p = 0.004) and caspase-9 (p <0.001) expression. Caspase-8 and caspase-9 expression was significantly higher in K4 than in K3, with expression restored to levels comparable to the untreated control group (K1). Conclusion Moderate-intensity exercise restored caspase-8 and caspase-9 expression suppressed by DMBA exposure, suggesting preservation of apoptotic signaling in DMBA-induced Wistar rats.
- Open Access
- 16 October 2025
- Published by Knowledge E DMCC in Sudan Journal of Medical Sciences
- Vol. 20 (3) , 291-325
Therapeutic Effects of Curcumin on Different Types of Oral Diseases: Evidence from Preclinical Animal Studies and Clinical Trials
Background: The present study aims to review and summarize the therapeutic effects of curcumin on different types of oral diseases, along with the mechanisms of action based on evidence. Methods: A comprehensive review of preclinical animal studies and clinical trials published from 2014 to 2024 in PubMed, Scopus, ScienceDirect, Web of Science, Wiley Online Library, and Google Scholar was conducted. Risk of bias was assessed using SYRCLE’s RoB tool for preclinical animal studies and Cochrane RoB 2 for clinical trials. Results: Based on the review, we highlight that curcumin has strong potential as a promising adjuvant therapeutic agent for various oral diseases, such as periodontal diseases (gingivitis and periodontitis), recurrent aphthous stomatitis, oral mucositis, oral lichen planus, oral leukoplakia, oral submucous fibrosis, and oral cancer, as evidenced by both preclinical animal studies and clinical trials. These effects are attributed to curcumin’s reported anti-inflammatory, antioxidant, antifungal, antimicrobial, immunomodulatory, and anticancer activities. We also found that no significant adverse side effects were reported from subjects given curcumin compared with those given conventional therapy. However, although curcumin offers significant therapeutic effects on oral diseases, we found limitations in clinical trials of curcumin on some diseases, especially oral cancer. Therefore, future studies related to clinical trials on some oral diseases with rigorous methods may be warranted. Conclusion: Curcumin seems promising as a therapeutic agent for oral diseases. However, further clinical trials with more rigorous methods and larger samples are strongly needed.
- 16 October 2025
- Published by Knowledge E DMCC in Sudan Journal of Medical Sciences
- Vol. 20 (3) , 291-325
Open AccessTherapeutic Effects of Curcumin on Different Types of Oral Diseases: Evidence from Preclinical Animal Studies and Clinical Trials
Background: The present study aims to review and summarize the therapeutic effects of curcumin on different types of oral diseases, along with the mechanisms of action based on evidence. Methods: A comprehensive review of preclinical animal studies and clinical trials published from 2014 to 2024 in PubMed, Scopus, ScienceDirect, Web of Science, Wiley Online Library, and Google Scholar was conducted. Risk of bias was assessed using SYRCLE’s RoB tool for preclinical animal studies and Cochrane RoB 2 for clinical trials. Results: Based on the review, we highlight that curcumin has strong potential as a promising adjuvant therapeutic agent for various oral diseases, such as periodontal diseases (gingivitis and periodontitis), recurrent aphthous stomatitis, oral mucositis, oral lichen planus, oral leukoplakia, oral submucous fibrosis, and oral cancer, as evidenced by both preclinical animal studies and clinical trials. These effects are attributed to curcumin’s reported anti-inflammatory, antioxidant, antifungal, antimicrobial, immunomodulatory, and anticancer activities. We also found that no significant adverse side effects were reported from subjects given curcumin compared with those given conventional therapy. However, although curcumin offers significant therapeutic effects on oral diseases, we found limitations in clinical trials of curcumin on some diseases, especially oral cancer. Therefore, future studies related to clinical trials on some oral diseases with rigorous methods may be warranted. Conclusion: Curcumin seems promising as a therapeutic agent for oral diseases. However, further clinical trials with more rigorous methods and larger samples are strongly needed.
- Open Access
- 4 September 2025
- Published by Instituto Mexicano del Seguro Social in Revista Urología Colombiana / Colombian Urology Journal
- Vol. 34 (3)
Periodontal disease and prostate cancer: a systematic review and meta-analysis
This study aims to determine the association between periodontal disease (PD) and prostate cancer (PC) using systematic review and meta-analysis. Any observational studies investigating the association between PD and PC published in PubMed, Scopus, ScienceDirect, and Google Scholar from inception to 2024 were reviewed. The Newcastle-Ottawa Scale was used to assess study quality. Stata version 17.0 software was used for all statistical analyses. The study's findings were reported as odds ratios (ORs) with 95% confidence intervals (CIs) through fixed-or random-effects model meta-analysis. Nine studies involving 621,982 male participants aged ≥ 20 years were finally included in this meta-analysis. The fixed-effects model meta-analysis revealed a significant association between PD and PC (OR = 1.19; 95% CI = 1.12-1.28; p = 0.0000). The present meta-analysis was robust based on the results of sensitivity analysis. This meta-analysis demonstrates a significant association between PD and PC, potentially driven by chronic inflammation and migration of periodontal pathogenic bacterial.
- 4 September 2025
- Published by Instituto Mexicano del Seguro Social in Revista Urología Colombiana / Colombian Urology Journal
- Vol. 34 (3)
Open AccessPeriodontal disease and prostate cancer: a systematic review and meta-analysis
This study aims to determine the association between periodontal disease (PD) and prostate cancer (PC) using systematic review and meta-analysis. Any observational studies investigating the association between PD and PC published in PubMed, Scopus, ScienceDirect, and Google Scholar from inception to 2024 were reviewed. The Newcastle-Ottawa Scale was used to assess study quality. Stata version 17.0 software was used for all statistical analyses. The study's findings were reported as odds ratios (ORs) with 95% confidence intervals (CIs) through fixed-or random-effects model meta-analysis. Nine studies involving 621,982 male participants aged ≥ 20 years were finally included in this meta-analysis. The fixed-effects model meta-analysis revealed a significant association between PD and PC (OR = 1.19; 95% CI = 1.12-1.28; p = 0.0000). The present meta-analysis was robust based on the results of sensitivity analysis. This meta-analysis demonstrates a significant association between PD and PC, potentially driven by chronic inflammation and migration of periodontal pathogenic bacterial.
- Open Access
- 16 July 2025
- Published by African Journals Online (AJOL) in Rwanda Medical Journal
- Vol. 82 (2) , 41-52
Association between periodontitis and sperm quality: a sysstematic review and meta-analysis
INTRODUCTION: The present study was conducted to evaluate the association between periodontitis and sperm quality. METHODS: A systematic review and meta-analysis of any observational studies published from inception to August 2024 in Scopus, PubMed, ScienceDirect, EBSCO, and Google Scholar was performed. A JBI checklist was used to assess the risk of bias. Statistical analysis was performed using Stata version 17. Fixed- or random-effects model meta-analyses were used and reported as pooled odds ratio (OR) and 95% confidence interval (CI). RESULTS: Six studies involving 987 men aged ≥21 years were included in the systematic review, and four of them were included in the meta-analysis. Periodontitis was significantly associated with any sperm abnormalities (OR = 1.86; 95% CI = 1.32-2.60; p = 0.0003). In subgroup analysis, significant associations were found between periodontitis and sperm quality in Asian populations (OR = 2.13; 95% CI = 1.48-3.07; p = 0.0001) and subnormal sperm count (OR = 2.08; 95% CI = 1.03- 4.23; p = 0.04). When stratified by the severity, moderate-to-severe periodontitis was associated with sperm quality (OR = 2.76; 95% CI = 1.78-4.26; p <0.0001). CONCLUSION: This study shows that periodontitis is associated with any sperm abnormalities.
- 16 July 2025
- Published by African Journals Online (AJOL) in Rwanda Medical Journal
- Vol. 82 (2) , 41-52
Open AccessAssociation between periodontitis and sperm quality: a sysstematic review and meta-analysis
INTRODUCTION: The present study was conducted to evaluate the association between periodontitis and sperm quality. METHODS: A systematic review and meta-analysis of any observational studies published from inception to August 2024 in Scopus, PubMed, ScienceDirect, EBSCO, and Google Scholar was performed. A JBI checklist was used to assess the risk of bias. Statistical analysis was performed using Stata version 17. Fixed- or random-effects model meta-analyses were used and reported as pooled odds ratio (OR) and 95% confidence interval (CI). RESULTS: Six studies involving 987 men aged ≥21 years were included in the systematic review, and four of them were included in the meta-analysis. Periodontitis was significantly associated with any sperm abnormalities (OR = 1.86; 95% CI = 1.32-2.60; p = 0.0003). In subgroup analysis, significant associations were found between periodontitis and sperm quality in Asian populations (OR = 2.13; 95% CI = 1.48-3.07; p = 0.0001) and subnormal sperm count (OR = 2.08; 95% CI = 1.03- 4.23; p = 0.04). When stratified by the severity, moderate-to-severe periodontitis was associated with sperm quality (OR = 2.76; 95% CI = 1.78-4.26; p <0.0001). CONCLUSION: This study shows that periodontitis is associated with any sperm abnormalities.
- Open Access
- 17 June 2025
- Published by OPRA Publications in International Journal of Advanced Multidisciplinary Research and Studies
- Vol. 5 (3) , 1337-1345
A Review: Cigarettes Trigger Chronic Inflammation in the Body
Background Cigarettes are a controversial product with the highest smoking rate in Indonesia, which contain harmful substances like nicotine and tar that can cause chronic inflammation, as shown by increased levels of IL-8, TNF-α, and ROS in saliva. Even though people are aware of the dangers, most still smoke without paying attention to the impact on health. Long-term smoking can weaken the immune system and increase Non-communicable illness risks including cancer. Objective To explain how smoking can trigger chronic inflammation in the body. Discussion Cigarettes are a combination of chemicals. When cigarettes are inhaled, incomplete combustion can be deposited in the body. Generally speaking, there are two major categories of cigarette components: Gas components (92%) and solid components or particles (8%). The gas elements of cigarette smoke consist of oxides, carbon monoxide, ammonia, hydrogen cyanide, carbon dioxide, and hydrocarbons. Cigarette particles consist of nicotine, tar, benzopyrene, cadmium, benzanthracene, indole, henol, carbarzol and cresol. These chemicals are poisonous and unpleasant, and they can also raise the release of salivary ROS and pro-inflammatory cytokines like TNF-a and IL-8. Conclusion Cigarettes increase salivary ROS, TNF-α, and IL-8 production, which can cause chronic inflammation in the body.
- 17 June 2025
- Published by OPRA Publications in International Journal of Advanced Multidisciplinary Research and Studies
- Vol. 5 (3) , 1337-1345
Open AccessA Review: Cigarettes Trigger Chronic Inflammation in the Body
Background Cigarettes are a controversial product with the highest smoking rate in Indonesia, which contain harmful substances like nicotine and tar that can cause chronic inflammation, as shown by increased levels of IL-8, TNF-α, and ROS in saliva. Even though people are aware of the dangers, most still smoke without paying attention to the impact on health. Long-term smoking can weaken the immune system and increase Non-communicable illness risks including cancer. Objective To explain how smoking can trigger chronic inflammation in the body. Discussion Cigarettes are a combination of chemicals. When cigarettes are inhaled, incomplete combustion can be deposited in the body. Generally speaking, there are two major categories of cigarette components: Gas components (92%) and solid components or particles (8%). The gas elements of cigarette smoke consist of oxides, carbon monoxide, ammonia, hydrogen cyanide, carbon dioxide, and hydrocarbons. Cigarette particles consist of nicotine, tar, benzopyrene, cadmium, benzanthracene, indole, henol, carbarzol and cresol. These chemicals are poisonous and unpleasant, and they can also raise the release of salivary ROS and pro-inflammatory cytokines like TNF-a and IL-8. Conclusion Cigarettes increase salivary ROS, TNF-α, and IL-8 production, which can cause chronic inflammation in the body.